A major role that cytotoxic T lymphocytes (CTLs) play in the immune response is the specific destruction of viral-infected cells and tissue from foreign grafts. Class I molecules encoded within the major histocompatibility complex are the target structures for these CTLs. Recently, viral-restricted CTLs have been shown to recognize viral peptides in association with class I molecules, while several studies with cloned alloreactive CTLs have indicated that these T cells can recognize class I-derived peptides in association with class I molecules. Together, these observations suggest that peptide binding is an important function of class I molecules. In this paper, we show that the recognition of a particular class I molecule by a bulk population of alloreactive CTLs can be altered by incubating with it a peptide derived from another class I molecule. Specifically, we used the hybrid D/Ldml molecule as a target structure together with the peptide Ld61-85, and we have shown that their associative recognition by Ld-specific CTLs depends on sequence and configuration of the peptide and is specific for Ld using a cold-target inhibition assay. Our results are discussed in light ofthree possible models for the target structure(s) that can be recognized by alloreactive CTLs and in terms of the role peptides may play during allorecognition.
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The major histocompatibility complex controls cellular interactions among lymphocytes and antigen-presenting cells; these interactions play crucial roles during transplantation or allograft rejection and viral infection (1, 2) . Two families of gene products encoded within the major histocompatibility complex mediate these effects: class I molecules are target structures for cytotoxic T lymphocytes (CTLs), while class II molecules are recognized by helper T cells.
Class II molecules have clearly been shown to present "processed" antigen or synthetic peptides to helper T cells (3) (4) (5) . In contrast, only recently has work from several laboratories indicated that class I molecules may also bind synthetic peptides, thereby forming target structures that can be recognized by CTLs. Germinal studies on the specificity of cloned influenza-restricted CTLs have shown that synthetic peptides, whose sequences are derived from the nucleoprotein of the virus, can be recognized in conjunction with a class I molecule (6) . In addition, influenza hemagglutinin-specific CTLs can recognize the transmembrane sequence ofhemagglutinin in the context ofthe Kd molecule (7). Maryanski et al. have shown that cloned CTLs can recognize a human class I peptide in the context of the H-2Kd molecule (8) , while certain cloned HLA-A2-specific alloreactive CTLs have been shown to recognize a complex ofan A2 peptide and the Aw69 molecule (9) . The class I-derived peptide Ld61-85, together with the Dk molecule, has also been shown to be recognized by certain Ld-specific CTL clones (10) . All these observations suggest that peptide binding is an important function of class I molecules. Thus, class I as well as class II molecules may function in an analogous manner by binding and presenting antigenic fragments to T lymphocytes. In addition, these results raise the intriguing possibility that class I molecules are normally expressed with peptide bound to them and that not only viral-restricted CTLs, but also alloreactive CTLs, may routinely involve the recognition of such complexes of class I plus peptide (11) .
That class I molecules may indeed bind peptides and, in fact, possess a tertiary structure compatible with this role has been demonstrated with the elucidation of the threedimensional structure of the HLA-A2 molecule (12, 13) . This study shows that the extracellular portion of a class I molecule (it is normally a transmembrane glycoprotein) is folded into three domains-al, a2, and a3. The a3 domain and .32-microglobulin, a noncovalently associated protein of Mr 12,000, are both homologous to immunoglobulin and fold, next to the cell membrane, in the 3 plus 4 fold reminiscent of true immunoglobulins. In contrast, the al and a2 domains each comprise an a-helix of -8 turns and four strands of ,8-pleated sheet; together these sheets form a platform that supports the two a-helices, which sit approximately parallel to each other and form a deep cleft that is lined with many of the amino acid side chains, which are polymorphic in class I molecules. Surprisingly, significant electron density was discovered within this cleft; although its origin is unknown, it may be due to peptide(s) derived from an intracellular protein or from the Epstein-Barr virus, which is known to have infected the cells from which the A2 protein was prepared. This study gives a rational molecular explanation for many experiments showing that CTLs recognize combinatorial determinants on both the al and a2 domains simultaneously (14-18) because of their three-dimensional proximity, and it suggests that the functional role of the high degree of polymorphism in the al and a2 domains may be to allow class I molecules to bind a host of seemingly unrelated peptides for recognition by CTLs (13) .
Given, therefore, that class I-derived peptides have previously been shown to associate with class I molecules, as assayed by certain specific cloned populations of CTLs of unknown frequency, we wished to determine whether we could deliberately alter the recognition of a class I molecule by a bulk population of alloreactive CTLs simply by incubating a class I-derived peptide with it.
In this study, we used the hybrid D/Ldml (dml) class I molecule as a target structure (19) . This molecule was originally isolated from the mutant BlO.D2-H-2dml mouse and has Dd-specific residues from amino acids 1-114 with the remainder of the molecule being identical to Ld. Thus, if one assumes that its three-dimensional structure is analogous to the HLA-A2 molecule, it will have an al a-helix identical to
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Dd, while its a2 a-helix is identical to Ld. We used this molecule to determine whether a synthetic peptide Ld61-85, whose sequence is identical to the al a-helix of LU, could interact with the dml molecule and thereby create Ld-specific epitopes using the a2 a-helix of the hybrid molecule together with a peptide that mimics the al a-helix.
In this paper, we show that Ld-specific CTLs, generated in a mixed lymphocyte reaction, can indeed recognize the dml molecule to which the synthetic peptide Ld61-85 is bound. We also demonstrate, by using a cold-target inhibition assay, that this recognition depends on the sequence and configuration of the peptide and is specific for Ld. Finally, we discuss the implications these observations may have for allorecognition.
MATERIALS AND METHODS
Mice. BALB/cJ (H-2d) and B1O.D2/nSnJ (H-2d) mice were purchased from The Jackson Laboratories. BALB/c-H-2dm2 and B10.D2-H-2dml mice were bred in the Norris Cancer Center vivarium (University of Southern California School of Medicine).
Transfectants. K31-25 and K2a-7 are L-cell transfectants expressing dml and Ld molecules, respectively, and were kindly provided by R. S. Goodenow (Berkeley) (19, 20) . K23-19 was a gift from I. Stroynowski (California Institute of Technology) and is an L-cell line transfected with a hybrid gene that has three 5' exons (L, al, a2) encoding Ld with the remaining exons being Dd, denoted (LLD)d (15) . L cells (H-2k) transfected with the thymidine kinase (tk) gene alone and P815 (H-2d), a mastocytoma, were used as controls.
Generation of CTLs. Alloreactive CTLs were generated in a mixed lymphocyte reaction. Responder spleen cells (2 x 106 cells per ml) were cocultured with irradiated (2000 R) stimulator spleen cells (4 x 106 cells per ml) in RPMI 1640 medium supplemented with 10% fetal calf serum, 200 mM glutamine, nonessential amino acids, sodium pyruvate, penicillin (100 ,ug/ml), streptomycin (100 ttg/ml), and 2.5 x 10-5 M 2-mercaptoethanol for 5 days at 37°C in 5% C02/95% air. Ld-specific CTLs were generated by using BALB/c-H-2dm2 responder cells and BALB/c stimulator cells. Likewise, dml-specific CTLs were generated by using B1O.D2 responder cells and B10.D2-H-2dm1 stimulator cells.
Cell-Mediated Lympholysis. Specific cell lysis was measured by a standard 4-hr 5'Cr-release assay (21). Target cells were incubated with peptide and 51Cr together, or 51Cr alone, for 1 hr at 37°C and were then washed four times. Percentage specific lysis was calculated as follows: % specific lysis = (cpm experimental -cpm spontaneous)/(cpm maximalcpm spontaneous) x 100. Spontaneous release in all experiments was _15% and values are triplicate means with SEM _3% unless indicated otherwise in the figures. For anti-Ld CTLs, specific lysis of P815 was always >90% at 100:1 effector/target cell ratio.
Cold-Target Inhibition. Specific cell lysis of labeled targets in the presence of various unlabeled targets was performed by the 51Cr-release assay described above. Percentage inhibition was calculated as 1 -(% specific lysis in presence of unlabeled targets/% specific lysis in absence of unlabeled targets) x 100.
Synthesis of Peptides. Peptides were synthesized on an Applied Biosystems model 430A automated peptide synthesizer using modified Merrifield chemistry. They were cleaved from the resin and deprotected by using either hydrogen fluoride (Peninsular Laboratories and Applied Biosystems) or trifluoromethane sulfonic acid (22 (23) . However, evidence to be discussed later suggests that peptide Ld61-85 may possess features that would stabilize a-helix formation; alternatively, peptide binding in the cleft of a class I molecule may induce secondary structure. To determine whether CTL recognition depends on the configuration of amino acids in the peptide, we decided to synthesize a peptide, denoted Ld*61-85, which is identical in sequence to Ld but differed in its stereochemistry by incorporating D-amino acids every 5 or 6 residues. Cell-mediated lympholysis assays demonstrate that, unlike its chemically analogous peptide Ld61-85 containing all L-amino acids, this peptide could not form Ld-specific CTL determinants when incubated with dml molecules. The results are shown in Fig. 3 . We conclude, therefore, that the configuration of the amino acids of the peptide is indeed important for its interaction with a class I molecule, although we do not yet know its precise secondary structure. To determine the sequence specificity required for Ld recognition, we have synthesized peptides from other parts of the Ld molecule and have shown that they do not create Ld epitopes (our data are not shown but are summarized in Fig.  4 ). We have also synthesized two peptides whose sequences are derived from analogous regions from two other class I molecules, Kb and Dd, neither of which can create Ld determinants. We have also prepared a series of truncated peptides and have shown that removal of five amino acids at the carboxyl terminus does not affect LO activity, in contrast to the removal of two amino acids at the amino terminus, which markedly reduces recognition. This observation suggests that for recognition by Ld-specific CTLs, amino acids in the amino portion of the al a-helix are particularly important. This is in agreement with conclusions drawn from site-directed mutagenesis experiments in which Ddspecific amino acids were introduced into the Ld molecule (24, 25) . Interestingly, two short peptides Ld61-72 and Ld73-85, which together comprise our original peptide Ld61-85, do not yield Ld reactivity either separately or together. This suggests that both may compete for a high-affinity binding site and are therefore positioned on dml differently than is Ld61-85. Alternatively, since these peptides are only 12 or 13 amino acids long, they are very unlikely to possess any secondary structure in solution, a feature that may be important for Ld-specific CTL recognition.
DISCUSSION
Our studies demonstrate that the synthetic peptide Ld61-85 can associate with the dml molecule and that this complex is recognized by anti-Ld-specific CTLs in a specific manner.
These results may have important implications for the role peptides may play in allorecognition.
At least three hypothetical models can be postulated for the class I target structure that is recognized by alloreactive CTLs.
(i) Class I molecules are always expressed on the cell surface with their clefts filled with peptide. The identity ofthe peptide is immaterial to the T-cell receptor (TCR), since the receptor in this model recognizes only side chains, both polymorphic and constant, on the class I molecule itself.
(ii) Class I molecules can be expressed on the cell surface without a peptide being present. The TCR would then recognize two juxtaposed a-helices of the class I molecule in the absence of peptide. One Alternatively, the receptors on T cells may be so heterogenous in their specificities that all three models may pertain to some degree;
The simplest interpretation of our results would favor model ii, in which the Ldspecific CTLs recognize two juxtaposed a-helices, ift this case, the al a-helix is contributed by the peptide Ld61-85, while the other is the a2 a-helix of the dml molecule. This is schematically presented in Fig.  5 . This would mean that Ld-specific CTLs could recognize the Ld molecule itself without a cryptic peptide being bound. The high specific lysis we observe when the anti-LU CTLs are presented with dml-Ld61-85 complexes suggests that the number of CTLs that recognize these complexes is significant. However, we need to clone these cells to estimate the exact frequency with which these CTLs occur in the bulk population. This analysis is required to interpret our data in terms of the role that peptides may play in allorecognition.
In Our studies clearly show that LU epitope formatijh -depends not only on the sequence of the peptide, as would be expected, but also on peptide configuration. A Chou and Fasman algorithm predicts that the peptide Ld61-85 should form an amphipathic a-helix, and indeed it possesses several features that would stabilize a-helix formation (29) . For example, its amino-terminal residue is a glutamic acid that can interact with the helix dipole; glutamic acid is the most effective amino acid in this regard (30) . The peptide contains a glutamic acid at position 71 and an arginine at position 75, 4 residues away, which could form a stabilizing salt bridge or ion pair (31) . In addition, this sequence is presumably an a-helix in the class I molecule itself. Our data suggest that QlaSs I molecules can bind peptides that may possess.the propensity to form amphipathic a-helices in solution. Such behavior has already been observed for peptides that bind to class II molecules (32, 33 
